Handelen Carl Zeiss Meditec AG - AFX CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Spread | 0.56 | ||||||||
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.017913% | ||||||||
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | -0.004309% | ||||||||
Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
Min. verhandelde hoeveelheid | 1 | ||||||||
Valuta | EUR | ||||||||
Marge | 20% | ||||||||
Effectenbeurs | Germany | ||||||||
Handelscommissie | 0% |
*Information provided by Capital.com
Prev. Close* | 131.27 |
Open* | 131.92 |
1-Jaarlijkse Verandering* | -11.49% |
Dagelijks bereik* | 131.22 - 133.77 |
52 wekelijks bereik | 101.75-152.20 |
Weekgemiddelde volume (10 dagen) | 120.37K |
Gemiddeld volume (3 maanden) | 1.83M |
Marktkapitalisatie | 11.74B |
P/E Ratio | 38.32 |
Uitstaande Aandelen | 89.44M |
Omzet | 1.96B |
EPS | 3.42 |
Dividend (opbrengst %) | 0.8381 |
Beta | 0.65 |
Volgende inkomsten datum | May 9, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
---|---|---|---|---|---|---|
Mar 21, 2023 | 131.27 | -3.80 | -2.81% | 135.07 | 135.17 | 127.33 |
Mar 20, 2023 | 134.47 | -2.25 | -1.65% | 136.72 | 138.66 | 134.37 |
Mar 17, 2023 | 137.51 | 0.20 | 0.15% | 137.31 | 138.11 | 136.07 |
Mar 16, 2023 | 136.92 | 0.45 | 0.33% | 136.47 | 137.07 | 132.67 |
Mar 15, 2023 | 135.07 | -2.94 | -2.13% | 138.01 | 138.21 | 133.07 |
Mar 14, 2023 | 138.06 | 2.24 | 1.65% | 135.82 | 140.16 | 135.62 |
Mar 13, 2023 | 135.77 | 0.30 | 0.22% | 135.47 | 136.32 | 132.47 |
Mar 10, 2023 | 135.47 | 1.15 | 0.86% | 134.32 | 136.07 | 134.17 |
Mar 9, 2023 | 136.37 | 3.65 | 2.75% | 132.72 | 136.52 | 132.22 |
Mar 8, 2023 | 133.27 | -0.20 | -0.15% | 133.47 | 134.42 | 132.32 |
Mar 7, 2023 | 134.82 | -1.85 | -1.35% | 136.67 | 137.41 | 134.32 |
Mar 6, 2023 | 133.62 | 0.25 | 0.19% | 133.37 | 134.12 | 132.47 |
Mar 3, 2023 | 133.52 | 0.85 | 0.64% | 132.67 | 133.81 | 131.87 |
Mar 2, 2023 | 131.57 | 3.94 | 3.09% | 127.63 | 131.97 | 127.43 |
Mar 1, 2023 | 128.53 | 2.75 | 2.19% | 125.78 | 129.23 | 125.53 |
Feb 28, 2023 | 125.78 | -2.80 | -2.18% | 128.58 | 128.93 | 125.33 |
Feb 27, 2023 | 129.43 | -1.25 | -0.96% | 130.68 | 130.88 | 129.23 |
Feb 24, 2023 | 130.13 | -0.60 | -0.46% | 130.73 | 131.97 | 129.08 |
Feb 23, 2023 | 130.18 | -0.40 | -0.31% | 130.58 | 131.57 | 130.03 |
Feb 22, 2023 | 129.78 | -0.10 | -0.08% | 129.88 | 131.02 | 128.58 |
Carl Zeiss Meditec AG Events
Tijd (UTC) (UTC) | Land | Evenement |
---|---|---|
No events scheduled |
- Jaarlijks
- Per kwartaal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale inkomsten | 1646.79 | 1335.45 | 1459.32 | 1280.86 | 1189.9 |
Inkomsten | 1646.79 | 1335.45 | 1459.32 | 1280.86 | 1189.9 |
Kosten van opbrengsten, totaal | 679.572 | 589.935 | 627.437 | 570.471 | 533.163 |
Brutowinst | 967.213 | 745.517 | 831.884 | 710.389 | 656.733 |
Totale bedrijfskosten | 1273.17 | 1157.9 | 1194.66 | 1083.73 | 1009.07 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 363.98 | 349.161 | 393.913 | 353.646 | 337.647 |
Onderzoek & Ontwikkeling | 232.066 | 218.804 | 173.312 | 159.628 | 145.792 |
Bedrijfsresultaat | 373.614 | 177.552 | 264.659 | 197.13 | 180.83 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | -32.12 | -21.351 | -34.497 | -20.449 | 8.29 |
Overige, Netto | -2.444 | 22.516 | -0.304 | 2.502 | -0.564 |
Netto inkomen voor belastingen | 339.05 | 178.717 | 229.858 | 179.183 | 188.556 |
Netto inkomen na belastingen | 237.519 | 123.421 | 160.579 | 126.23 | 135.778 |
Minderheidsbelang | -1.243 | -1.036 | -0.823 | 0.233 | -1.333 |
Netto inkomen voor extra. Posten | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Netto inkomen | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Verwaterd Netto Inkomen | 236.276 | 122.385 | 159.756 | 126.463 | 134.445 |
Verwaterd Gewogen Gemiddelde Aandelen | 89.4406 | 89.4406 | 89.4406 | 89.4406 | 85.5867 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 2.64171 | 1.36834 | 1.78617 | 1.41393 | 1.57086 |
Dividends per Share - Common Stock Primary Issue | 0.9 | 0.5 | 0.65 | 0.55 | 0.55 |
Verwaterde Genormaliseerde Winst per Aandeel | 2.62254 | 1.41621 | 1.826 | 1.44229 | 1.46924 |
Ongebruikelijke uitgaven (inkomsten) | -2.447 | 0 | -7.478 | ||
Other Operating Expenses, Total | 0 | -0.015 | -0.058 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totale inkomsten | 445.229 | 410.176 | 448.585 | 430.834 | 398.456 |
Inkomsten | 445.229 | 410.176 | 448.585 | 430.834 | 398.456 |
Kosten van opbrengsten, totaal | 176.654 | 177.401 | 180.772 | 169.459 | 167.701 |
Brutowinst | 268.575 | 232.775 | 267.813 | 261.375 | 230.755 |
Totale bedrijfskosten | 342.273 | 335.808 | 357.771 | 310.724 | 309.186 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 95.837 | 97.871 | 111.48 | 86.291 | 84.081 |
Onderzoek & Ontwikkeling | 69.692 | 60.536 | 65.566 | 54.927 | 57.404 |
Ongebruikelijke uitgaven (inkomsten) | 0.09 | 0 | -0.047 | 0.047 | 0 |
Bedrijfsresultaat | 102.956 | 74.368 | 90.814 | 120.11 | 89.27 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | -8.662 | -20.181 | -11.82 | -3.625 | -9.995 |
Overige, Netto | 25.805 | -0.115 | -1.944 | -0.217 | -0.181 |
Netto inkomen voor belastingen | 120.099 | 54.072 | 77.05 | 116.268 | 79.094 |
Netto inkomen na belastingen | 92.095 | 38.009 | 54.819 | 81.199 | 55.173 |
Minderheidsbelang | -1.367 | -0.069 | -0.743 | 0.389 | -0.864 |
Netto inkomen voor extra. Posten | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Netto inkomen | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Verwaterd Netto Inkomen | 90.728 | 37.94 | 54.076 | 81.588 | 54.309 |
Verwaterd Gewogen Gemiddelde Aandelen | 89.8297 | 89.5912 | 89.8211 | 88.6826 | 89.0312 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.01 | 0.42348 | 0.60204 | 0.92 | 0.61 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0.9 | 0 | 0 |
Verwaterde Genormaliseerde Winst per Aandeel | 1.01077 | 0.42348 | 0.60167 | 0.92037 | 0.61 |
- Jaarlijks
- Per kwartaal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totaal vlottende activa | 1604.02 | 1290.51 | 1304.33 | 1251.06 | 1207.89 |
Geldmiddelen en kortetermijnbeleggingen | 7.439 | 6.202 | 22.639 | 7.843 | 8.315 |
Cash | 7.439 | 6.202 | 22.639 | 6.678 | 3.925 |
Geldmiddelen & Equivalenten | |||||
Totale Vorderingen, Netto | 1294.65 | 979.93 | 1000.34 | 981.046 | 935.904 |
Accounts Receivable - Trade, Net | 185.94 | 165.158 | 205.789 | 192.33 | 195.256 |
Total Inventory | 286.375 | 286.36 | 268.322 | 248.092 | 234.303 |
Prepaid Expenses | 9.502 | 8.144 | 10.759 | 9.352 | 9.986 |
Other Current Assets, Total | 6.049 | 9.871 | 2.266 | 4.723 | 19.38 |
Total Assets | 2395.97 | 2014.85 | 2022.13 | 1662.05 | 1623.11 |
Property/Plant/Equipment, Total - Net | 199.555 | 135.265 | 116.752 | 62.632 | 58.696 |
Property/Plant/Equipment, Total - Gross | 379.88 | 320.308 | 280.47 | 196.305 | 174.346 |
Accumulated Depreciation, Total | -180.325 | -185.043 | -163.718 | -133.673 | -115.65 |
Goodwill, Net | 328.714 | 326.51 | 338.094 | 185.638 | 174.313 |
Intangibles, Net | 153.698 | 145.221 | 144.336 | 74.087 | 68.491 |
Long Term Investments | 6.713 | 4.108 | 5.173 | 0.122 | 19.3 |
Note Receivable - Long Term | 9.191 | 9.225 | 10.961 | 9.29 | 14.565 |
Other Long Term Assets, Total | 94.079 | 104.014 | 102.484 | 79.227 | 79.855 |
Total Current Liabilities | 448.118 | 297.584 | 339.6 | 280.18 | 316.078 |
Accounts Payable | 145.465 | 91.679 | 118.12 | 101.437 | 100.463 |
Accrued Expenses | 137.816 | 109.294 | 115.657 | 98.181 | 80.259 |
Notes Payable/Short Term Debt | 0.645 | 0.209 | 0.192 | 15.71 | 5.733 |
Current Port. of LT Debt/Capital Leases | 19.341 | 15.512 | 14.661 | 3.529 | 2.819 |
Other Current Liabilities, Total | 144.851 | 80.89 | 90.97 | 61.323 | 126.804 |
Total Liabilities | 736.641 | 583.133 | 623.69 | 368.588 | 407.731 |
Total Long Term Debt | 178.425 | 140.636 | 151.837 | 7.321 | 3.588 |
Long Term Debt | 76.496 | 87.543 | 109.009 | 0 | 0.593 |
Capital Lease Obligations | 101.929 | 53.093 | 42.828 | 7.321 | 2.995 |
Deferred Income Tax | 15.438 | 17.166 | 18.198 | 5.234 | 8.918 |
Minority Interest | 18.056 | 18.841 | 18.517 | 21.17 | 26.358 |
Other Liabilities, Total | 76.604 | 108.906 | 95.538 | 54.683 | 52.789 |
Total Equity | 1659.33 | 1431.72 | 1398.44 | 1293.46 | 1215.38 |
Common Stock | 89.441 | 89.441 | 89.441 | 89.441 | 89.441 |
Additional Paid-In Capital | 620.137 | 620.137 | 620.137 | 620.137 | 620.137 |
Retained Earnings (Accumulated Deficit) | 1000.48 | 808.922 | 744.673 | 632.486 | 555.215 |
Other Equity, Total | -50.729 | -86.783 | -55.812 | -48.6 | -49.416 |
Total Liabilities & Shareholders’ Equity | 2395.97 | 2014.85 | 2022.13 | 1662.05 | 1623.11 |
Total Common Shares Outstanding | 89.4406 | 89.4406 | 89.4406 | 89.4406 | 89.4406 |
Korte Termijn Investeringen | 0 | 1.165 | 4.39 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totaal vlottende activa | 1674.57 | 1604.02 | 1451.74 | ||
Geldmiddelen en kortetermijnbeleggingen | 21.589 | 17.918 | 17.352 | ||
Geldmiddelen & Equivalenten | 8.401 | 7.439 | 8.315 | ||
Korte Termijn Investeringen | 13.188 | 10.479 | 9.037 | ||
Totale Vorderingen, Netto | 1298.01 | 1274.3 | 1140.1 | ||
Accounts Receivable - Trade, Net | 156.475 | 185.94 | 164.928 | ||
Total Inventory | 328.867 | 286.375 | 274.078 | ||
Other Current Assets, Total | 26.105 | 25.422 | 20.211 | ||
Total Assets | 2526.01 | 2395.97 | 2217.7 | ||
Property/Plant/Equipment, Total - Net | 205.703 | 199.555 | 189.302 | ||
Goodwill, Net | 379.934 | 328.714 | 323.349 | ||
Intangibles, Net | 163.484 | 153.698 | 144.045 | ||
Long Term Investments | 6.843 | 6.713 | 4.843 | ||
Note Receivable - Long Term | 9.096 | 9.191 | 8.339 | ||
Other Long Term Assets, Total | 86.374 | 94.079 | 96.077 | ||
Total Current Liabilities | 499.258 | 448.118 | 347.866 | ||
Accounts Payable | 140.474 | 145.465 | 123.336 | ||
Accrued Expenses | 109.277 | 127.787 | 92.307 | ||
Notes Payable/Short Term Debt | 0 | 0 | 0 | ||
Current Port. of LT Debt/Capital Leases | 18.97 | 19.341 | 17.876 | ||
Other Current Liabilities, Total | 230.537 | 155.525 | 114.347 | ||
Total Liabilities | 788.612 | 736.641 | 672.152 | ||
Total Long Term Debt | 189.666 | 178.425 | 192.216 | ||
Long Term Debt | 88.588 | 76.496 | 90.194 | ||
Capital Lease Obligations | 101.078 | 101.929 | 102.022 | ||
Deferred Income Tax | 15.035 | 15.438 | 16.932 | ||
Minority Interest | 18.693 | 18.056 | 17.705 | ||
Other Liabilities, Total | 65.96 | 76.604 | 97.433 | ||
Total Equity | 1737.39 | 1659.33 | 1545.55 | ||
Common Stock | 89.441 | 89.441 | 89.441 | ||
Additional Paid-In Capital | 620.137 | 620.137 | 620.137 | ||
Retained Earnings (Accumulated Deficit) | 1048.65 | 1000.48 | 909.534 | ||
Other Equity, Total | -20.833 | -50.729 | -73.565 | ||
Total Liabilities & Shareholders’ Equity | 2526.01 | 2395.97 | 2217.7 | ||
Total Common Shares Outstanding | 89.4406 | 89.4406 | 89.4406 |
- Jaarlijks
- Per kwartaal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto-inkomen/Beginsaldo | 237.519 | 123.421 | 160.579 | 126.23 | 135.778 |
Geldmiddelen uit Operationele Activiteiten | 362.663 | 178.527 | 219.634 | 187.207 | 37.732 |
Geldmiddelen uit Operationele Activiteiten | 61.584 | 60.425 | 48.37 | 31.282 | 24.235 |
Niet-Geldelijke Posten | 110.074 | 58.691 | 76.373 | 54.526 | 47.269 |
Cash Taxes Paid | 97.908 | 58.964 | 65.07 | 48.364 | 54.73 |
Contant Betaalde Rente | 1.629 | 1.365 | 1.903 | 1.94 | 1.559 |
Veranderingen in het Operationeel Kapitaal | -46.514 | -64.01 | -65.688 | -24.831 | -169.55 |
Geldmiddelen uit Investeringsactiviteiten | -75.2 | -70.947 | -145.846 | -28.874 | -55.931 |
Kapitaaluitgaven | -66.101 | -44.986 | -46.711 | -34.756 | -39.022 |
Overige Cash Flow investeringsposten, Totaal | -9.099 | -25.961 | -99.135 | 5.882 | -16.909 |
Geldmiddelen uit Financieringsactiviteiten | -285.889 | -122.961 | -58.637 | -157.237 | 14.494 |
Financiering van Cash Flow Posten | -223.862 | -48.775 | 4.321 | -104.529 | -259.854 |
Total Cash Dividends Paid | -44.72 | -58.136 | -49.192 | -49.192 | -37.565 |
Uitgifte (Aflossing) van Schulden, Netto | -17.307 | -16.05 | -13.766 | -3.516 | -3.123 |
Wisselkoerseffecten | -0.337 | -1.056 | 0.81 | 1.657 | -1.08 |
Nettowijziging in Geldmiddelen | 1.237 | -16.437 | 15.961 | 2.753 | -4.785 |
Uitgifte (Aflossing) van aandelen, netto | 0 | 315.036 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 130.104 | 101.501 | |||
Cash From Operating Activities | 74.484 | 151.878 | |||
Cash From Operating Activities | 33.045 | 29.924 | |||
Non-Cash Items | 16.671 | 44.673 | |||
Cash Taxes Paid | 61.722 | 41.015 | |||
Cash Interest Paid | 0.679 | 0.67 | |||
Changes in Working Capital | -105.336 | -24.22 | |||
Cash From Investing Activities | -54.311 | -28.769 | |||
Capital Expenditures | -35.335 | -23.26 | |||
Other Investing Cash Flow Items, Total | -18.976 | -5.509 | |||
Cash From Financing Activities | -18.33 | -124.663 | |||
Financing Cash Flow Items | -9.441 | -116.396 | |||
Issuance (Retirement) of Debt, Net | -8.889 | -8.267 | |||
Foreign Exchange Effects | -0.881 | -0.31 | |||
Net Change in Cash | 0.962 | 2.113 |
Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
---|---|---|---|---|---|---|
Carl Zeiss Group | Corporation | 59.14 | 52895153 | 35776 | 2022-11-15 | |
Capital Research Global Investors | Investment Advisor | 4.9912 | 4464153 | -46868 | 2023-02-13 | LOW |
Capital World Investors | Investment Advisor | 1.6403 | 1467117 | 0 | 2023-01-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1486 | 1027305 | 1286 | 2023-02-28 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.8941 | 799668 | -11471 | 2023-01-31 | LOW |
Groupama Asset Management | Investment Advisor | 0.8665 | 775034 | -37628 | 2022-09-30 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.7614 | 681009 | -125 | 2023-02-28 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 0.7572 | 677231 | -8165 | 2023-02-28 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.7341 | 656620 | -14037 | 2023-02-28 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 0.6837 | 611545 | -19183 | 2023-01-31 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.5952 | 532334 | 153016 | 2023-02-28 | HIGH |
Candriam Luxembourg S.A. | Investment Advisor | 0.5894 | 527175 | -10543 | 2023-01-31 | HIGH |
La Financière de l'Echiquier | Investment Advisor | 0.5405 | 483394 | -6 | 2022-11-30 | LOW |
Oddo BHF Asset Management S.A.S | Investment Advisor/Hedge Fund | 0.4626 | 413722 | -16606 | 2023-01-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.442 | 395285 | 17110 | 2023-02-28 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.4095 | 366292 | -451602 | 2022-12-31 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 0.332 | 296921 | -10699 | 2023-02-28 | LOW |
Credit Mutuel Asset Management | Investment Advisor | 0.2971 | 265728 | 250534 | 2022-12-31 | HIGH |
Columbia Threadneedle Investments (UK) | Investment Advisor/Hedge Fund | 0.2487 | 222410 | -1214 | 2022-11-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.2357 | 210844 | 1186 | 2023-01-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group500K+
Handelaren
92K+
Actieve klanten per maand
$53M+
Maandelijks beleggingsvolume
$30M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Carl Zeiss Meditec Company profile
Over Carl Zeiss Meditec AG
Carl Zeiss Meditec AG is een in Duitsland gevestigde onderneming op het gebied van medische technologie en hulpmiddelen. Het biedt complete oplossingen voor de diagnose en behandeling van ophtalmische ziekten, visualisatieoplossingen voor microchirurgie en andere technologieën, zoals intraoperatieve radiotherapie. Het bedrijf is actief in twee segmenten: Oogheelkundige Apparaten en Microchirurgie. Het segment Oogheelkundige Apparaten omvat activiteiten op het gebied van de oogheelkunde, zoals intraoculaire lenzen, chirurgische visualisatieoplossingen en medische laser- en diagnosesystemen. Het segment Microchirurgie omvat activiteiten op het gebied van neuro-, oor-, neus- en keelchirurgie, evenals de activiteiten op het gebied van intraoperatieve bestraling. De Onderneming heeft verschillende productievestigingen in Europa, de Verenigde Staten en Azië.
Industry: | Advanced Medical Equipment & Technology (NEC) |
Göschwitzer Straße 51-52
JENA
THUERINGEN 07745
DE
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 500.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen